314 related articles for article (PubMed ID: 25622927)
21. Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.
Ekstedt M; Franzén LE; Mathiesen UL; Kechagias S
Scand J Gastroenterol; 2012 Jan; 47(1):108-15. PubMed ID: 22126450
[TBL] [Abstract][Full Text] [Related]
22. Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency.
Sookoian S; Puri P; Castaño GO; Scian R; Mirshahi F; Sanyal AJ; Pirola CJ
Liver Int; 2017 Apr; 37(4):611-619. PubMed ID: 27614103
[TBL] [Abstract][Full Text] [Related]
23. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
24. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
25.
Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Moriya K; Yotsuyanagi H; Koike K
World J Gastroenterol; 2018 Aug; 24(32):3617-3625. PubMed ID: 30166857
[TBL] [Abstract][Full Text] [Related]
26. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers.
Kamada Y; Ono M; Hyogo H; Fujii H; Sumida Y; Mori K; Tanaka S; Yamada M; Akita M; Mizutani K; Fujii H; Yamamoto A; Takamatsu S; Yoshida Y; Itoh Y; Kawada N; Chayama K; Saibara T; Takehara T; Miyoshi E
Hepatology; 2015 Nov; 62(5):1433-43. PubMed ID: 26199205
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque.
Yu LY; Hu KC; Liu CJ; Hung CL; Bair MJ; Chen MJ; Wang HY; Wu MS; Shih SC; Liu CC
Medicine (Baltimore); 2019 Mar; 98(9):e14672. PubMed ID: 30817593
[TBL] [Abstract][Full Text] [Related]
28. The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.
Gunn NT; Shiffman ML
Clin Liver Dis; 2018 Feb; 22(1):109-119. PubMed ID: 29128050
[TBL] [Abstract][Full Text] [Related]
29. Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis.
Jiang Y; Han T; Zhang ZG; Zhang Y; Qi FX
Rev Esp Enferm Dig; 2018 Jan; 110(1):19-24. PubMed ID: 29271227
[TBL] [Abstract][Full Text] [Related]
30. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
[TBL] [Abstract][Full Text] [Related]
32. Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis.
Alkhouri N; Alisi A; Okwu V; Matloob A; Ferrari F; Crudele A; De Vito R; Lopez R; Feldstein AE; Nobili V
Dig Dis Sci; 2015 Aug; 60(8):2353-9. PubMed ID: 25764498
[TBL] [Abstract][Full Text] [Related]
33. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
34. Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.
Corey KE; Misdraji J; Gelrud L; King LY; Zheng H; Malhotra A; Chung RT
Dig Dis Sci; 2015 Aug; 60(8):2523-8. PubMed ID: 25840922
[TBL] [Abstract][Full Text] [Related]
35. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
36. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.
Zhou BG; Yang HJ; Xu W; Wang K; Guo P; Ai YW
Helicobacter; 2019 Jun; 24(3):e12576. PubMed ID: 30907050
[TBL] [Abstract][Full Text] [Related]
37. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.
Brunt EM; Clouston AD; Goodman Z; Guy C; Kleiner DE; Lackner C; Tiniakos DG; Wee A; Yeh M; Leow WQ; Chng E; Ren Y; Boon Bee GG; Powell EE; Rinella M; Sanyal AJ; Neuschwander-Tetri B; Younossi Z; Charlton M; Ratziu V; Harrison SA; Tai D; Anstee QM
J Hepatol; 2022 May; 76(5):1030-1041. PubMed ID: 35090960
[TBL] [Abstract][Full Text] [Related]
38. Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis.
Liu R; Liu Q; He Y; Shi W; Xu Q; Yuan Q; Lin Q; Li B; Ye L; Min Y; Zhu P; Shao Y
Medicine (Baltimore); 2019 Nov; 98(44):e17781. PubMed ID: 31689846
[TBL] [Abstract][Full Text] [Related]
39. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.
Chen C; Zhang C; Wang X; Zhang F; Zhang Z; Ma P; Feng S
Eur J Gastroenterol Hepatol; 2020 Jul; 32(7):857-866. PubMed ID: 31714387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
